Rapid City Regional Hospital Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2006
NCT00350298
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Rapid City Regional Hospital, Inc | Rapid City Regional Hospital, Rapid City, SD

Active Ingredients

Drugs in Phase 4 Trials (2)

clopidogrel (plavix) (1 trial)

ticagrelor (brilinta) (1 trial)

Drugs in Phase 2 Trials (2)

bezlotoxumab (zinplava) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Clostridium Infections (Phase 2)

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Myocardial Ischemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4